Evidence map›Paper›PMID 27561721›Full record

ArticleHaematologica2017

The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

Suzanna M van Walraven, Anneke Brand, Jack N A Bakker, Martin B A Heemskerk, Suzan Nillesen, Marc B Bierings, Laura B Bungener, Bouke G Hepkema, Arjan Lankester, Arnold van der Meer and 7 more

Abstract read
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Suzanna M van WalravenEuropdonor Foundation, Leiden, the Netherlands a.vanwalraven@sanquin.nl.
Anneke BrandSanquin, Amsterdam, the Netherlands.
Jack N A BakkerEuropdonor Foundation, Leiden, the Netherlands.
Martin B A HeemskerkDutch Transplant Foundation, Leiden, the Netherlands.
Suzan NillesenStem Cell Donor Bank Europdonor Nijmegen, University Medical Center Nijmegen St. Radboud, the Netherlands.
Marc B BieringsUniversity Medical Center Utrecht / Wilhelmina Kinderziekenhuis, Pediatric Stem Cell Transplantation Team, Leiden, the Netherlands.
Laura B BungenerUniversity Medical Center Groningen, Laboratory for Transplant Immunology, Leiden, the Netherlands.
Bouke G HepkemaUniversity Medical Center Groningen, Laboratory for Transplant Immunology, Leiden, the Netherlands.
Arjan LankesterLeiden University Medical Center, Willem Alexander Kinderziekenhuis, Department for Pediatric Stem Cell Transplantation, Leiden, the Netherlands.
Arnold van der MeerStem Cell Donor Bank Europdonor Nijmegen, University Medical Center Nijmegen St. Radboud, the Netherlands.
Kees SintnicolaasSanquin, Department of Transfusion Medicine, Rotterdam, the Netherlands.
Judith A E SomersSanquin, Department of Transfusion Medicine, Rotterdam, the Netherlands.
Eric SpieringsUniversity Medical Center Utrecht, Department of Immunology, HLA laboratory, Maastricht, the Netherlands.
Marcel G J TilanusUniversity Hospital Maastricht, Transplantation Immunology, Tissue Typing Laboratory, Maastricht, the Netherlands.
Christien E M VoorterUniversity Hospital Maastricht, Transplantation Immunology, Tissue Typing Laboratory, Maastricht, the Netherlands.
Jan J CornelissenErasmus University Medical Center, Department of Hematology, Rotterdam, the Netherlands.
Machteld OudshoornEuropdonor Foundation, Leiden, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Between 2001 and 2012, the number of unrelated donors registered worldwide increased from 7 to 21 million, and the number of public cord blood units increased to over 500,000. We addressed the question of whether this expansion resulted in higher percentages of patients reaching transplantation. Unrelated donor searches were evaluated for 3,124 eligible patients in the Netherlands in two cohorts (2001-2006, n=995; 2007-2012, n=2129), comparing results for patients of Northwestern European and non-Northwestern European origin. Endpoints were 'donor found' and 'transplantation reached'. The substantial growth of the donor inventory over the period studied did not increase the median number of potential unrelated donors (n=7) for non-Northwestern European patients, but almost doubled the number for Northwestern European patients from 42 to 71. Before and after 2007, an unrelated donor or cord blood was identified for 91% and 95%, respectively, of Northwestern European patients and for 65% and 82% of non-Northwestern European patients (P<0.0001). Non-Northwestern European patients more often needed a cord blood transplant. The degree of HLA matching was significantly lower for non-Northwestern European patients (P<0.0006). The time needed to identify a donor decreased for both populations. The percentage of Northwestern European patients reaching transplantation increased from 77% to 83% and for non-Northwestern European patients from 57% to 72% (P=0.0003). The increase of the global inventory resulted in more transplants for patients lacking a family donor, although the quality and quantity of (potential) haematopoietic cell grafts for patients of a non-Northwestern European descent remained inferior, indicating the need for adaptation of recruitment.

Indexed as

Hematopoietic Stem Cell TransplantationRegistriesTissue DonorsAdolescentAdultChildFemaleHistocompatibility TestingHumansMaleNeoplasmsNetherlandsPopulation GroupsYoung Adult

Identifiers

PMID27561721
PMCPMC5210248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.